Equity Profile

LIVN

LivaNova PLC

Health CareHealth Care Equipment$4.5B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

LivaNova PLC is a global medical technology company focused on developing innovative solutions for patients with cardiovascular and neurological conditions. Operating in the health care sector, LivaNova's products aim to improve patient outcomes and enhance the quality of life, making it a significant player in the health care equipment industry.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

$1.09

Revenue

Total revenue reflects the company's sales performance and growth potential, which is critical for assessing overall business health.

$381M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

In Q1 2026, LivaNova reported an EPS of $0.98, significantly surpassing the estimate of $0.72, resulting in a stock price increase of 15.05% the following day. The strong performance indicates positive momentum heading into the next earnings report.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are generally optimistic about LivaNova's upcoming earnings, expecting continued strong performance based on previous results. The consensus estimates suggest steady growth in both earnings and revenue.

Bull Case

If LivaNova can beat the EPS estimate of $1.09, it may signal robust demand for its products and potentially lead to a stock price rally.

Bear Case

Conversely, if the company fails to meet expectations, it could raise concerns about its growth trajectory and lead to a decline in stock price.

Key Metrics to Watch

EPS

$1.09

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

Revenue

$381M

Total revenue reflects the company's sales performance and growth potential, which is critical for assessing overall business health.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $1.09?

A beat on EPS could reinforce investor confidence and indicate strong operational performance.

What specific factors contributed to revenue growth this quarter?

Understanding the drivers behind revenue will help assess the sustainability of LivaNova's growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LivaNova's ability to capitalize on recent product innovations and market demand, which could lead to higher-than-expected revenue growth.

Supporting Evidence

LivaNova has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing in a significant move, suggesting that traders expect a surprise in either direction.

Key Risk

If LivaNova's revenue growth exceeds $381M, it could challenge the current consensus and lead to a positive reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will provide insights into LivaNova's ability to maintain its growth trajectory amid market challenges.

Bull Confirmed If

An EPS of $1.10 or higher would confirm strong demand and operational efficiency.

Bear Confirmed If

An EPS below $1.06 would raise concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential price movement, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests the stock could rise by around 2.92%, confirming strong growth and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further guidance.

Miss

A miss on earnings could lead to a decline in stock price, with historical data suggesting an average drop of around 2.92%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on new product launches and their expected impact on revenue.
2Insights into market demand trends for cardiovascular and neurological products.
3Updates on cost management strategies and their effect on profitability.
4Guidance on future revenue expectations and growth strategies.
5Any potential challenges or risks the company anticipates in the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

$1.09

Revenue

Total revenue reflects the company's sales performance and growth potential, which is critical for assessing overall business health.

$381M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LIVN Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+39.47%

Avg Stock Reaction

+2.92%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If LivaNova can beat the EPS estimate of $1.09, it may signal robust demand for its products and potentially lead to a stock price rally.

Bear Case

Conversely, if the company fails to meet expectations, it could raise concerns about its growth trajectory and lead to a decline in stock price.

Key Metrics to Watch

EPS

$1.09

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

Revenue

$381M

Total revenue reflects the company's sales performance and growth potential, which is critical for assessing overall business health.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will LivaNova's EPS exceed the consensus estimate of $1.09?

A beat on EPS could reinforce investor confidence and indicate strong operational performance.

What specific factors contributed to revenue growth this quarter?

Understanding the drivers behind revenue will help assess the sustainability of LivaNova's growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate LivaNova's ability to capitalize on recent product innovations and market demand, which could lead to higher-than-expected revenue growth.

Supporting Evidence

LivaNova has consistently beaten EPS estimates in the past, indicating strong operational performance.

The options market is pricing in a significant move, suggesting that traders expect a surprise in either direction.

Key Risk

If LivaNova's revenue growth exceeds $381M, it could challenge the current consensus and lead to a positive reevaluation of the stock.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will provide insights into LivaNova's ability to maintain its growth trajectory amid market challenges.

Bull Confirmed If

An EPS of $1.10 or higher would confirm strong demand and operational efficiency.

Bear Confirmed If

An EPS below $1.06 would raise concerns about the company's growth prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±21.07%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant potential price movement, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±21.1% while LIVN has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

55.5%

Calls (200)P/C Ratio: 0.67Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LivaNova beats expectations, history suggests the stock could rise by around 2.92%, confirming strong growth and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further guidance.

Miss

A miss on earnings could lead to a decline in stock price, with historical data suggesting an average drop of around 2.92%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on new product launches and their expected impact on revenue.
2Insights into market demand trends for cardiovascular and neurological products.
3Updates on cost management strategies and their effect on profitability.
4Guidance on future revenue expectations and growth strategies.
5Any potential challenges or risks the company anticipates in the upcoming quarters.